Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design.
Wang, Y., Dai, Y., Wu, X., Li, F., Liu, B., Li, C., Liu, Q., Zhou, Y., Wang, B., Zhu, M., Cui, R., Tan, X., Xiong, Z., Liu, J., Tan, M., Xu, Y., Geng, M., Jiang, H., Liu, H., Ai, J., Zheng, M.(2019) J Med Chem 62: 7473-7488
- PubMed: 31335138 
- DOI: 10.1021/acs.jmedchem.9b00510
- Primary Citation of Related Structures:  
6ITJ, 6IUO, 6IUP - PubMed Abstract: 
Alterations of fibroblast growth factor receptors (FGFRs) play key roles in numerous cancer progression and development, which makes FGFRs attractive targets in the cancer therapy. In the present study, based on a newly devised FGFR target-specific scoring function, a novel FGFR inhibitor hit was identified through virtual screening ...